Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DAISHIN CHEMICAL, Jul-Sep (2Q) Ordinary Profit Increases by 77%
4629 DAISHIN CHEMICAL CO.,LTD. 【J-GAAP】
Earnings ReportDAISHIN CHEMICAL CO.,LTD. <4629> [TSE Std] announced its financial results after the market closed on November 12th (15:45). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded 0.67 billion yen, an increase 74.0% compared to the same period last year, exceeded the previous forecast of 0.53 billion yen.
Progress toward the full-year plan of 1.05 billion yen was 63.8%, also surpassing the five-year average of 52.8%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease 22.3% from the same period last year to 0.38 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased 76.8% from the same period last year, reaching 0.49 billion yen. The operating profit margin improved from 2.9% in the same period last year to 5.6%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 16,079 | 462 | 532 | 355 | 77.8 | 56.7 | Nov 8, 2023 | J-GAAP |
| Apr - Sep, 2024 | 17,259 | 336 | 385 | 250 | 54.8 | 44.1 | Nov 12, 2024 | J-GAAP |
| Apr - Sep, 2025 | 16,952 | 630 | 670 | 451 | 98.7 | 63.8 | Nov 12, 2025 | J-GAAP |
| YoY | -1.8% | +87.5% | +74.0% | +80.4% | +80.0% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | 18,240 | 490 | 530 | 360 | 78.7 | 0 | May 14, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 16,952 | 630 | 670 | 451 | 98.7 | 0 | Nov 12, 2025 | J-GAAP |
| Revision Rate | -7.1% | +28.6% | +26.4% | +25.3% | +25.4% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 17,452 | 463 | 489 | 338 | 73.9 | 40 | May 14, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 19,068 | 360 | 380 | 269 | 58.8 | 40 | Nov 12, 2025 | J-GAAP |
| YoY | +9.3% | -22.2% | -22.3% | -20.4% | -20.4% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 32,461 | 825 | 939 | 627 | 137.1 | 40 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 34,711 | 799 | 874 | 588 | 128.6 | 40 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 36,020 | 990 | 1,050 | 720 | 157.4 | 40 | May 14, 2025 | J-GAAP |
| YoY | +3.8% | +23.9% | +20.1% | +22.4% | +22.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 8,731 | 252 | 280 | 185 | 40.6 | 2.9 | Nov 12, 2024 | J-GAAP |
| Oct - Dec, 2024 | 9,153 | 195 | 207 | 121 | 26.5 | 2.1 | Feb 13, 2025 | J-GAAP |
| Jan - Mar, 2025 | 8,299 | 268 | 282 | 217 | 47.4 | 3.2 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 8,432 | 156 | 175 | 119 | 26.1 | 1.9 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 8,520 | 474 | 495 | 332 | 72.6 | 5.6 | Nov 12, 2025 | J-GAAP |
| YoY | -2.4% | +88.1% | +76.8% | +79.5% | +79.1% |
Related Articles
TOKYO ROPE MFG, Jul-Sep (2Q) Ordinary Profit Increases by 40%
StemCell Institute, First Half Ordinary Profit Decreases by 48%, Jul-Sep Ordinary Profit Decreases by 51%
MAMEZO DIGITAL, 17% Increase in Undisclosed Ordinary Profit, Update Record High for Fifth Consecutive Term
SUGITA ACE, First Half Ordinary Profit Turns to Profit, Postponed Dividend for This Fiscal Year
Systems Engineering Consultants, Jul-Sep (2Q) Ordinary Profit Increases by 32%
TRANSGENIC, Jul-Sep (2Q) Ordinary Profit Turns to Profit
NAGANO KEIKI , First Half Ordinary Profit Decreases by 21%, Current Fiscal Year Dividend Revised Upward by 2 Yen
NIHON FALCOM, 5% Decrease in Ordinary Profit for The Current Fiscal Year
Petgo, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Turns to Loss
Kringle Pharma, The Current Fiscal Year's Net Income to Widen